Grifols | GRFS - Vermögenswerte

Aktienkurs
8.08
Täglich Wechseln
0.09 1.13%
Monatlich
4.80%
Jährlich
12.07%
Q2 Prognose
7.87




Vermögenswerte Veränderung Datum
Alaunos Therapeutics USD 3.72M 1.01M 2025-09
Arca Biopharma USD 488.62M 20.63M 2025-12
aTyr Pharma USD 515.34M 408.68M 2025-12
Bio Path USD 690K 56K 2025-09
Brainstorm Cell Therapeutics USD 1.02M 358K 2025-12
Capricor Therapeutics USD 355.95M 229.51M 2025-12
Cara Therapeutics USD 39.02M 4.73M 2025-09
Esperion Therapeutics USD 465.89M 101.87M 2025-12
GlaxoSmithKline GBP 61.12B 221M 2025-12
Grifols EUR 23.15B 142.7M 2025-12
Immunic USD 40.7M 20.72M 2025-09
Infinity Pharmaceuticals USD 21.23M 8.72M 2023-06
Minerva Neurosciences USD 97.97M 69.88M 2025-12
Nektar Therapeutics USD 280.41M 20.94M 2025-12
Sangamo BioSciences USD 97.56M 11.39M 2025-06
TherapeuticsMD USD 40.13M 1.96M 2024-06